We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.

Close

Planning application submitted for £60m Citylabs expansion

The UK's leading science and technology park operator Manchester Science Partnerships has submitted a planning application to Manchester City Council seeking approval for its proposed £60m expansion of the Citylabs campus, its biomedical centre of excellence.

If approved, the proposed developments - taken forward in a joint venture partnership with Central Manchester University Hospitals NHS Foundation Trust (CMFT) - are expected to boost Manchester's economy by more than £100m and bring 750 jobs to the city by 2020.

Located on the CMFT campus in the heart of Manchester's Innovation District, Corridor Manchester, Citylabs 2.0 and 3.0 will be targeted at health and medical technology companies.

MSP and CMFT have already received a number of expressions of interest from potential occupiers after showcasing Citylabs 2.0 and 3.0 during a recent trade mission to the US, which included meetings at the important global AdvaMed conference.

Citlyabs2.0

Proprosed Citylabs 2.0 design

Thomas Renn, Managing Director of Manchester Science Partnerships said: "After consulting with the local community and other stakeholders last month, we're pleased and excited to be bringing this ambitious development forward.

"The success of Citylabs 1.0 - which was fully let within 15 months of opening - has given us the confidence to invest in phases two and three, and we are sure demand will be strong for these high quality facilities located in a great physical and intellectual environment."

Keith Chantler, Director of Innovation at CMFT explained: "This joint partnership with MSP offers a fantastic opportunity for our patients, staff and our hospitals, to further develop the successful Citylabs cluster. Citylabs brings together NHS, university and industry partners to co-develop new healthcare technologies.

"By involving clinicians and patients from the start of the development and testing process, products are more likely to meet our future needs, and be rapidly adopted by the NHS and other health services across the world."

Chris Roberts, Development Director at Bruntwood, which has submitted the application on behalf of MSP, said: "The planned expansion of Citylabs is a great vote of confidence in Manchester and alongside the existing major developments on the city's Innovation District - such as Circle Square and the Alliance Manchester Business School - will reinforce its credentials as a world class location for science and technology businesses."

The submission of the planning application follows a public exhibition and consultation in November at Citylabs 1.0.

Phase 1, the £25m Citylabs 2.0 development will comprise 92,000 sq ft of lab and office space. Subject to planning permission being granted, construction work will begin in autumn 2017, with completion expected in late 2018.

Phase 2, Citylabs 3.0 will span 128,000 sq ft and integrate the development of new buildings with the Old Saint Mary's Hospital, an existing listed Victorian building. Construction is planned to start in summer 2018 and is due to be completed in 2020.

Citylabs2.0v2

The £35m project includes the restoration of a currently unused former chapel on the site, which is ear-marked for a café/ dining area with the potential for meeting room facilities.

The scheme also includes extensive external landscaping and the provision of new gardens for the enjoyment of Citylabs customers and other users of the hospital facilities. It comprises both new build and redevelopment of the Old Saint Mary's Hospital building on the corner of Oxford Road and Hathersage Road.

If approved, Citylabs 2.0 and 3.0 would be the first to be delivered through the Strategic Property Partnership between Manchester Science Partnerships, Bruntwood, and CMFT.

Announced in March 2016, the partnership supports the delivery of clinical care, research and innovation through the strategic development of CMFT's estate.

 

For more information please contact Influential: Chris Barry 07464 547297 or Jonathan Daly on 07881 301437


Notes for Editors

About MSP

Manchester Science Partnerships (MSP) is a Manchester based public-private partnership and the UK's leading science and technology park operator. MSP owns and operates 3m sq ft of office and laboratory space on its three main campuses - central Manchester, Citylabs 1.0 and Alderley Park.

MSP provides the right environments for innovation to flourish - supporting the growth of companies in the biomedical, ICT, industrial technologies, and digital/creative sectors, ranging in size from start-ups to European HQs and international centres of R&D excellence.

MSP's network of connections between innovators, scientists, investors and entrepreneurs brings businesses and people together to transform ideas into commercial reality.

MSP's shareholders are Bruntwood Ltd, The University of Manchester, Manchester Metropolitan University, Central Manchester University Hospitals NHS Foundation Trust and Manchester, Cheshire East and Salford City Councils.

- See more at: http://mspl.co.uk/


About CMFT

Central Manchester University Hospitals NHS Foundation Trust is a leading provider of specialist healthcare services in Manchester, treating more than a million patients every year. Its seven specialist hospitals (Manchester Royal Infirmary, Saint Mary's Hospital, Royal Manchester Children's Hospital, Manchester Royal Eye Hospital, University Dental Hospital of Manchester, Trafford General and Altrincham Hospitals) and community services are home to hundreds of world class clinicians and academic staff committed to finding patients the best care and treatments.  For more information, go to www.cmft.nhs.uk and www.research.cmft.nhs.uk.

 

About Bruntwood

Bruntwood is a family-owned and run property company that specialises in creating the right places for businesses to succeed. From a single desk for a day to a whole building for 25 years, we have solutions to suit a wide range of requirements.

With over 117 properties across four UK cities, we provide office space, co-work and studio space, serviced and virtual offices, meeting rooms and retail premises to companies across a range of different business sectors.

We don't see ourselves as a landlord but as our customers' property partner, making sure that their choice of premises adds the best possible benefit to the way their business works.

Over our 40-year history, we have developed a proven business model based on an innovative approach to property development, combined with a single-minded focus on the needs of the customer. We develop, let and manage all our own properties, allowing us to seamlessly control the whole experience to make sure it meets customers' expectations at every stage.

Bruntwood believes in sustainable cities that provide vibrant places for people to work and live. Each year we invest in the life of the cities we operate in by donating 10% of profits to arts, charitable, civic and environmental causes.

For further information please visit: bruntwood.co.uk